key: cord-0802924-n2l5fuxh
authors: Dowlati, Ehsan; Zhou, Tianzan; Sarpong, Kwadwo; Pivazyan, Gnel; Briscoe, Jessica; Fayed, Islam; Mualem, William; Black, Jordan; Kalhorn, Christopher G.; Nair, Mani N.; Felbaum, Daniel R.
title: In Reply to the Letter to the Editor Regarding “Case Volumes and Perioperative COVID-19 Incidence in Neurosurgical Patients During a Pandemic: Experiences at Two Tertiary Care Centers in Washington, DC”
date: 2020-11-03
journal: World Neurosurg
DOI: 10.1016/j.wneu.2020.08.159
sha: 5c1c146bccb152b5d2eb9abe4481a1d44f43fdaa
doc_id: 802924
cord_uid: n2l5fuxh

nan

In Reply to the Letter to the Editor Regarding "Case Volumes and Perioperative COVID-19 Incidence in Neurosurgical Patients During a Pandemic: Experiences at Two Tertiary Care Centers in Washington, DC" W e appreciate Raj et al. 1 for taking interest in our article regarding the incidence of coronavirus disease 2019 in neurosurgical patients during the pandemic 2 and providing their commentary entitled "Letter to the Editor Regarding: "Case Volumes and Perioperative Coronavirus Disease 2019 Incidence in Neurosurgical Patients During a Pandemic: Experiences at Two Tertiary Care Centers in Washington, DC." We are grateful for the opportunity to respond to this thoughtful and insightful letter.

We humbly agree with all the points listed by the authors. Some of these points, including the classification of cases according to the urgency, the percentage of COVID-19epositive patients, and regional limitation were addressed and listed as weaknesses in our study. The classification of cases as elective, urgent, or emergent has remained somewhat subjective and could be influenced by surgeon interpretation. Certainly, this is an area that requires further standardization or a centralized decision-making process as we determine how to risk stratify our operative patients in pandemic settings.

The primary point of interest in our study was the evaluation of patients who had tested negative for COVID-19 but who then had developed COVID-19 in the postoperative hospitalization period. The 2.8% positive rate was reported as a rate of nosocomial infection during the postoperative period. This was attained by dividing the number of positive postoperative COVID-19 tests by the number of total postoperative COVID-19 tests (which had only included patients with a confirmed preoperative negative test result). Therefore, the percentage was computed from a population of patients who had all received postoperative COVID-19 tests. We agree that inherent imperfectness was present in the testing and also that asymptomatic patients might not have been captured; thus, the results should be interpreted cautiously.

Specifically, the issue that Raj et al. 1 stated regarding nosocomial transmission to asymptomatic patients is a true concern that, unfortunately, we were unable to answer in our study because not all patients had undergone COVID-19 testing in the postoperative period. Attaining a percentage closer to the true postoperative infection rate among our population would require an estimate of the number of asymptomatic patients who had had nosocomial transmission of COVID-19. Statistical modeling has been performed, which estimated the proportion of asymptomatic patients with COVID-19 be 17.9% (95% confidence interval, 15.5e 20.2%). 3 Extrapolating this estimate to our patient population in which 5 patients were found to be positive postoperatively would estimate that 1 additional patient was missed by the lack of testing of asymptomatic postoperative patients. This would estimate the overall rate of nosocomial transmission at 6 of 306 patients who had tested negative preoperatively, or 2.0%. Of course, inaccuracies exist in estimating the true nosocomial transmission rate using this method; hence, we reported a postoperative nosocomial infection rate of 2.8% among a population of patients who had received a postoperative COVID-19 test rather than the entire postoperative population.

Despite this limitation, we believe that our results have contributed objective data amidst all the conjectures and editorials that could help minimize the spread of misinformation as we learn more about this new disease. 4 At the least, the studies will have something to support pursuing elective cases or give guidance to departments and hospital administration. To the note of extending the work to postpandemic periods, we intend to do exactly that. Now that neurosurgical services have restarted their elective cases and the neurosurgical caseload patterns are changing further, we hope to report changes in the COVID-19 rate and testing patterns. We have increased the length of our study and are in the process of reviewing 3 months of clinical data after the peak COVID-19 pandemic period to 1) observe any change in the incidence and 2) to confirm the benefit of the modified medically necessary, time sensitive score for risk stratification at these institutions. Stay tuned.

Again, we appreciate the commentary from Raj et al. 1 and the opportunity to clarify some points and expand on the focus of our study. We encourage others to study their respective populations in relationship to transmission risk, especially as hospitals increase their elective caseloads. As stated by the authors of the commentary, this just "might represent the tip of the iceberg."

Letter to editor regarding: "case volumes and perioperative coronavirus disease 2019 incidence in neurosurgical patients during a pandemic: experiences at two tertiary care centers in

Case volumes and perioperative coronavirus disease 2019 incidence in neurosurgical patients during a pandemic: experiences at two tertiary care centers in

Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship

Misinformation in the COVID-19 era